The series of cardiac biomarker parameters of Wantai BioPharm are complete and have excellent performance. They include relevant indicators for cardiovascular diseases such as myocardial injury, myocardial infarction, and heart failure, providing comprehensive and accurate diagnostic support for cardiovascular diseases in clinical practice. The highly sensitive detections of Hs-cTnT and Hs-cTnI can identify myocardial injury at an early stage. BNP and NT-proBNP help with the assessment of heart failure conditions and prognosis management. Combined with characteristic indicators such as H-FABP, ST2, and Lp-PLA2, etc., it can meet diverse clinical needs, provide reliable diagnostic evidence for doctors, facilitate precise diagnosis and treatment, and jointly safeguard the life defense line of patients!